4 Diop AG, De Boer HM, Mandlhate C, et al. The global campaign 31
against epilepsy in Africa. Acta Trop 2003; 87: 149–59.
5 Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in 32
developing countries: where do we go from here?
Bull World Health Organ 2001; 79: 344–51.
6 Meinardi H, Scott RA, Reis R, et al. The treatment gap in epilepsy: 33
the current situation and ways forward. Epilepsia 2001; 42: 136–49.
7 MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and
lifetime prevalence of neurological disorders in a prospective 34
community-based study in the UK. Brain 2000; 123: 665–76.
8 Sander JW. The epidemiology of epilepsy revisited. 35
Curr Opin Neurol 2003; 16: 165–70.
9 Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in
Europe—a systematic review. Eur J Neurol 2005; 12: 245–53. 36
10 Heaney DC, MacDonald BK, Everitt A, et al. Socioeconomic variation
in incidence of epilepsy: prospective community based study in south 37
east England. BMJ 2002; 325: 1013–16.
11 Sander JW. Infectious agents and epilepsy. In: Knobler S,
O'Connor S, Lemon SM, Najafi M, eds. The infectious etiology of 38
chronic diseases: defining the relationship, enhancing the research
and mitigating the effects. Washington: The National Academies
Press, 2004: 93–99.
12 Everitt AD, Sander JW. Incidence of epilepsy is now higher in elderly 39
people than children. BMJ 1998; 316: 780.
13 Sander JW, Bell GS. Reducing mortality: an important aim of epilepsy 40
management. J Neurol Neurosurg Psychiatry 2004; 75: 349–51.
14 Morgan CL, Kerr MP. Epilepsy and mortality: a record linkage study 41
in a U.K. population. Epilepsia 2002; 43: 1251–55.
15 Granger N, Convers P, Beauchet O, et al. First epileptic seizure in the 42
elderly: electroclinical and etiological data in 341 patients.
Rev Neurol (Paris) 2002; 158: 1088–95. 43
16 Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002; 2:
751–62. 44
17 Garcia HH, Gonzalez AE, Evans CA, Gilman RH, for the
Cysticercosis Working Group in Peru. Taenia solium cysticercosis.
Lancet 2003; 362: 547–56. 45
18 Maguire JH. Tapeworms and seizures—treatment and prevention.
N Engl J Med 2004; 350: 215–17.
19 Carter JA, Neville BG, White S, et al. Increased prevalence of epilepsy 46
associated with severe falciparum malaria in children. Epilepsia 2004;
45: 978–81. 47
20 Medina MT, Duron RM, Martinez L, et al. Prevalence, incidence, and
etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 48
2005; 46: 124–31.
21 Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and
toxocariasis: a population-based case-control study in rural Bolivia. 49
Neurology 2002; 58: 1256–61.
22 Boussinesq M, Pion SD, Demanga N, et al. Relationship between 50
onchocerciasis and epilepsy: a matched case-control study in the
Mbam Valley, Republic of Cameroon. Trans R Soc Trop Med Hyg 2002;
96: 537–41.
51
23 MacDonald BK, Johnson AL, Goodridge DM, et al. Factors predicting
prognosis of epilepsy after presentation with seizures. Ann Neurol
52
2000; 48: 833–41.
24 Brodie MJ, Kwan P. Staged approach to epilepsy management.
Neurology 2002; 58 (suppl 5): S2–8.
53
25 Dlugos DJ, Sammel MD, Strom BL, et al. Response to first drug trial
predicts outcome in childhood temporal lobe epilepsy. Neurology
2001; 57: 2259–64.
26 Kwan P, Sander JW. The natural history of epilepsy: an 54
epidemiological view. J Neurol Neurosurg Psychiatry 2004; 75: 1376–81.
27 Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy
and the management of refractory epilepsy in a specialist clinic. Q JM 55
1999; 92: 15–23.
28 Gaitatzis A, Carroll K, Majeed A, et al. The epidemiology of the
comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 56
1613–22.
29 Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in
the first 11 to 14 years after diagnosis: multivariate analysis of a long- 57
term, prospective, population-based cohort. Ann Neurol 2001; 49:
336–44.
30 Gaitatzis A, Johnson AL, Chadwick DW, et al. Life expectancy in 58
people with newly diagnosed epilepsy. Brain 2004; 127: 2427–32.
